Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 27, 2024	Sep. 29, 2023
Cash Flows From Operating Activities
Net (loss) income	$ (86,286)	$ 15,187
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Stock-based compensation	3,304	1,547
Depreciation and amortization	11,646	13,186
Equity in loss (earnings) of unconsolidated joint ventures	779	(9,570)
Return on investment in unconsolidated joint ventures	610	14,220
ERP pre-implementation asset impairment	10,428	0
Gain on sale of assets	(20,585)	(31,749)
Other	1,892	111
Changes in operating assets and liabilities:
Accounts receivable, net	663	(12,012)
Contract assets	(2,418)	(10,134)
Accounts payable	(12,149)	24,221
Contract liabilities	(18,157)	(41,797)
Accrued salaries, wages and benefits	2,489	(2,073)
Accrued expenses	34,165	(22,042)
Other assets and liabilities	7,436	(3,871)
Net cash used in operating activities	(66,183)	(64,776)
Cash Flows From Investing Activities
Purchases of property, plant and equipment	(9,963)	(6,140)
Proceeds from sale of assets	31,608	34,983
Unconsolidated joint venture equity contributions	(3,460)	(19,670)
Return of investments in unconsolidated joint ventures	204	3,980
Net cash provided by investing activities	18,389	13,153
Cash Flows From Financing Activities
Net borrowings on Credit Facility	42,000	0
Net (repayments of) borrowings on Revolving Credit Facility	(29,619)	33,722
Other, net	(1,924)	(1,028)
Net cash provided by financing activities	10,457	32,694
Net decrease in cash, cash equivalents and restricted cash	(37,337)	(18,929)
Cash, cash equivalents and restricted cash, beginning of period	63,910	82,085
Cash, cash equivalents and restricted cash, end of period	26,573	63,156
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	25,962	61,862
Restricted cash	611	1,294
Total cash, cash equivalents and restricted cash	$ 26,573	$ 63,156